1-3 of 3 results for subject:Misuse
Librarians' tools
- Search time
- 0.181 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Misuse
- We searched for
- subject_t:Misuse OR subject_t:"Substance misuse" OR subject_ses:92056
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for the Home Department, whether she plans to take steps to (a) regulate the use and (b) prevent substance abuse of nitrous oxide.
To ask the Secretary of State for the Home Department, whether she plans to take steps to (a) regulate the use and (b) prevent substance abuse of nitrous oxide.
The Government is concerned about the harms of nitrous oxide to those, often young people, who misuse this drug.
It is already an offence under the Psychoactive Substances Act 2016 to import, export, produce, supply, offer to supply, or possess with intent to supply, nitrous oxide. For the offence to be made out, the defendant must intend to consume the substance, or know or be reckless as to whether it will be consumed by another person, for its psychoactive effect.
These offences carry a maximum sentence of seven years’ imprisonment, or a fine, or both. It is also an offence to possess nitrous oxide in a custodial institution, for which the maximum sentence is two years’ imprisonment, or a fine, or both. Medicinal products are exempted from these controls.
In September 2021 the former Home Secretary requested the Advisory Council on the Misuse of Drugs (ACMD) conduct an updated harms assessment of Nitrous Oxide and consider whether it should be considered for control under the Misuse of Drugs Act 1971. Once the ACMD publish their advice, we will consider their recommendations closely and respond in due course.
To ask the Secretary of State for Health and Social Care, what guidance has been issued to Tees Esk and Wear Valleys NHS Foundation Trust to help ensure Pregabalin is not misused in patients who consume alcohol and smoke while being prescribed that drug.
To ask the Secretary of State for Health and Social Care, what guidance has been issued to Tees Esk and Wear Valleys NHS Foundation Trust to help ensure Pregabalin is not misused in patients who consume alcohol and smoke while being prescribed that drug.
No specific guidance has been issued. Pregabalin is a controlled substance and the British National Formulary states that healthcare professionals should evaluate patients for a history of drug misuse before prescribing pregabalin and observe patients for the development of signs of misuse and dependence.
To ask the Secretary of State for Health and Social Care, what guidance his Department has provided to Tees Esk and Wear Valleys NHS Foundation Trust to help ensure Clozapine is not misused in patients who consume alcohol or smoke while being prescribed that drug.
To ask the Secretary of State for Health and Social Care, what guidance his Department has provided to Tees Esk and Wear Valleys NHS Foundation Trust to help ensure Clozapine is not misused in patients who consume alcohol or smoke while being prescribed that drug.
No specific guidance has been issued.
The product information for clozapine for healthcare professionals and patients advises against drinking alcohol during treatment with that drug. The Medicines and Healthcare products Regulatory Agency provided a Drug Safety Update which recommends that blood concentration of clozapine should be monitored for toxicity in clinical situations, such as during smoking cessation or if a patient transfers to e-cigarettes. The British National Formulary advises that dose adjustment may be necessary if a patient’s smoking habits change during treatment with clozapine.